MedPath

CRESEMBA

CRESEMBA

Approved
DIN Number

02483998

Drug Class

Human

Market Date

May 31, 2019

Company
HC

avir pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02483998
AIG Number0161030002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J02AC05 ISAVUCONAZOLE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:14.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE)Active
Strength: 200 MG / VIAL
Monograph: ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.